Share |

Healthcare Industry Updates

MediPoint: Aortic Stent Grafts – Global Analysis and Market Forecasts

User Rating: / 1
Written by Global Data, Circulated by JMC IT MAHAL PVT.LTD.   
Aortic stent grafts are most commonly used to reinforce a weak spot in an artery, which is known as an aneurysm. The stent grafts are designed to seal tightly with the patient’s native artery above and below the aneurysm, and are used to treat abdominal aortic aneurysms as well as thoracic aortic aneurysms. Aortic aneurysms, as opposed to aneurysms found elsewhere in the body, are potentially very serious, as a burst aorta results in massive internal bleeding that can be fatal unless treated rapidly by an experienced emergency medical team.
Read more...
 

Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update

User Rating: / 2
Written by Global Data, Circulated by JMC IT MAHAL PVT.LTD.   
During the forecast period from 2012–2022, the growth of the UC market will be driven largely by the entry of Simponi and Entyvio, which will favor the increased uptake of biologics in the US, 5EU, Japan, and Canada. Although the number of UC prevalent cases is plateauing in the West, globally, the number of cases is rising, a phenomenon that will contribute to market growth over the next decade. Another event affecting the market is the launch of biosimilars, given the patent expiry of the UC blockbusters, Remicade and Humira, in the US in 2018 and 2016, respectively.
Read more...
 

Macular Edema and Macular Degeneration - Global Drug Forecast and Market Analysis to 2023

User Rating: / 1
Written by Global Data, Circulated by JMC IT MAHAL PVT.LTD.   
Macular Edema is a condition where fluid accumulates on the macula, leading to vision impairment or in severe cases even vision loss. The three main types of ME are diabetic macular edema (DME), and macular edema following either a central or branch retinal vein occlusion (ME-CRVO and ME-BRVO). Age-related macular degeneration (AMD) is a painless eye condition which leads to gradual, irreversible, loss of central vision, and is one of the leading causes of blindness among people aged 50 and over in the developed world.
Read more...
 

PharmaPoint: HER2-Positive Breast Cancer – Global Drug Forecast and Market Analysis to 2023

User Rating: / 1
Written by Global Data, Circulated by JMC IT MAHAL PVT.LTD.   
HER2-positive breast cancer is the second most common cancer in the world and the most common cancer in women worldwide. This report focuses on the current treatment landscape, unmet needs, current pipeline, and commercial opportunities in the HER2-positive breast cancer market, with coverage of multiple settings of the disease including neoadjuvant, adjuvant, first-, second-, third-, and fourth-line metastatic.
Read more...
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Results 1 - 4 of 1114

Upcoming Events

Value Beyond the Pill USA 2014
3rd-04th Dec 2014
Philadelphia, USA
Org: eyeforpharma
URL: WEBSITE

Please Click Here to submit the latest information about your company and we are here to share it across the Healthcare Industry worldwide.

Organizations (A-Z)

A B C D E
F G H I J
K L M N O
P Q R S T
U V X Y Z
Improve your Healthcare Business with our e-Marketing Plans


Advertise Here to Improve your Business and Get Global Reach..!

Bemis Healthcare

Bemis Healthcare Ltd.

Bio Cote Healthcare

Bio Cote Healthcare Ltd.

Sorin Group Healthcare

Sorin Group Healthcare

Ests Autoclaves

ESTS Autoclaves